{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:26:14Z","timestamp":1793964374392,"version":"4.8.0"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study aimed to identify and analyze immunogenic cell death (ICD)-related multi-omics features in bladder cancer (BLCA) using single-cell RNA sequencing (scRNA-seq) and bulk RNA-seq data. By integrating these datasets, we sought to construct a prognostic signature (ICDRS) and explore its clinical and biological implications, including its association with immune cell infiltration, tumor microenvironment (TME), and drug sensitivity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Publicly available datasets from TCGA and GEO, including scRNA-seq (GSE222315, 9 samples) and bulk RNA-seq (TCGA-BLCA, 403 samples; GSE13507, 160 samples), were analyzed. Single-cell data were processed using Seurat, and ICD scores were calculated using single-sample gene set enrichment analysis (ssGSEA). Weighted gene co-expression network analysis (WGCNA) identified ICD-related modules, and machine learning algorithms (Lasso, Ridge, CoxBoost) were employed to construct the ICDRS. Survival analysis, immune infiltration, pathway enrichment, and drug sensitivity were evaluated to validate the model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The ICDRS, based on eight key genes (IL32, AHNAK, ANXA5, FN1, GSN, CNN3, FXYD3, CTSS), effectively stratified BLCA patients into high- and low-risk groups with significant differences in overall survival (OS, P &amp;lt; 0.001). High ICDRS scores were associated with immune-suppressive TME, including increased infiltration of T cells CD4 memory resting (P = 0.02) and macrophages M0\/M1\/M2 (P = 0.01). Pathway enrichment revealed correlations with cholesterol homeostasis, epithelial-mesenchymal transition (EMT), and KRAS signaling. Drug sensitivity analysis showed high-risk groups were resistant to Cisplatin (P = 0.003), Mitomycin C (P = 0.01), and Paclitaxel (P = 0.004), with IC50 values significantly higher than low-risk groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The ICDRS serves as a robust prognostic biomarker for BLCA, offering insights into tumor immune evasion mechanisms and potential therapeutic targets. Its integration with clinical features enhances personalized treatment strategies, highlighting the importance of ICD in BLCA immunotherapy and precision medicine. The model\u2019s predictive accuracy and biological relevance were validated across multiple datasets, underscoring its potential for clinical application.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1572034","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T05:26:43Z","timestamp":1745299603000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Advancing personalized, predictive, and preventive medicine in bladder cancer: a multi-omics and machine learning approach for novel prognostic modeling, immune profiling, and therapeutic target discovery"],"prefix":"10.3389","volume":"16","author":[{"given":"Han","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13167-020-00206-1","article-title":"EPMA. 10th anniversary of the european association for predictive, preventive and personalised (3P) medicine - EPMA world congress supplement 2020","volume":"11","author":"Golubnitschaja","year":"2020","journal-title":"Epma J"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(22)01188-6","article-title":"Current best practice for bladder cancer: a narrative review of diagnostics and treatments","volume":"400","author":"Comp\u00e9rat","year":"2022","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21631","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.v130.9","article-title":"Insights on recent innovations in bladder cancer immunotherapy","volume":"130","author":"Abd El-Salam","year":"2022","journal-title":"Cancer Cytopathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/kjm2.12375","article-title":"Mechanisms of immunogenic cell death and immune checkpoint blockade therapy","volume":"37","author":"Lin","year":"2021","journal-title":"Kaohsiung J Med Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.925290","article-title":"Immunogenic cell death and role of nanomaterials serving as therapeutic vaccine for personalized cancer immunotherapy","volume":"13","author":"Catanzaro","year":"2022","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s13167-023-00327-3","article-title":"Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicine and based on a 101-combination machine learning computational framework","volume":"14","author":"Liu","year":"2023","journal-title":"Epma J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.5114\/wo.2014.47136","article-title":"The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge","volume":"19","author":"Tomczak","year":"2015","journal-title":"Contemp Oncol (Pozn)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: Archive for functional genomics data sets\u2013update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1137\/18m1216134","article-title":"Clustering with t-SNE, provably","volume":"1","author":"Linderman","year":"2019","journal-title":"SIAM J Math Data Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4341","article-title":"Identification of novel subtypes based on ssGSEA in immune-related prognostic signature for tongue squamous cell carcinoma","volume":"10","author":"Jin","year":"2021","journal-title":"Cancer Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10895","article-title":"LASSO regression","volume":"105","author":"Ranstam","year":"2018","journal-title":"Br J Surg"},{"key":"B19","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1186\/s12967-023-04366-2","article-title":"Identification of memory B-cell-associated miRNA signature to establish a prognostic model in gastric adenocarcinoma","volume":"21","author":"Liu","year":"2023","journal-title":"J Trans Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245376","article-title":"Ridge regression and its applications in genetic studies","volume":"16","author":"Arashi","year":"2021","journal-title":"PLoS One"},{"key":"B21","volume-title":"Package \u2018CoxBoost\u2019","author":"Binder","year":"2015"},{"key":"B22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/bioinformatics\/btq617","article-title":"Improved performance on high-dimensional survival data by application of Survival-SVM","volume":"27","author":"Van Belle","year":"2011","journal-title":"Bioinformatics"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9868.2005.00503.x","article-title":"Regularization and variable selection via the elastic net","volume":"67","author":"Zou","year":"2005","journal-title":"J R Stat Soc Ser B: Stat Method"},{"key":"B24","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1186\/1753-6561-3-s7-s25","article-title":"Elastic-net regularization approaches for genome-wide association studies of rheumatoid arthritis","volume":"3","author":"Cho","year":"2009","journal-title":"BMC Proc"},{"key":"B25","article-title":"Package \u2018plsRcox\u2019","author":"Bertrand","year":"2022"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.4625698","article-title":"plsRcox, Cox-Models in a high dimensional setting in R. Proc User","author":"Bertrand","year":"2014"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1198\/016214505000000628","article-title":"Prediction by supervised principal components","volume":"101","author":"Bair","year":"2006","journal-title":"J Am Stat Assoc"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1214\/08-AOAS169","article-title":"Random survival forests","author":"Ishwaran","year":"2008"},{"key":"B29","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4842-3564-5_6","article-title":"Gradient boosting machine","volume-title":"Pro Machine Learning Algorithms: A hands-on Approach to Implementing Algorithms in python and R","author":"Ayyadevara","year":"2018"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4103\/crst.crst_230_22","article-title":"A narrative review of survival analysis in oncology using R","volume":"5","author":"Pawar","year":"2022","journal-title":"Cancer Research Stats Treat"},{"key":"B31","volume-title":"Package \u2018timeROC\u2019","author":"Blanche","year":"2019"},{"key":"B32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1109\/tkde.2005.50","article-title":"Using AUC and accuracy in evaluating learning algorithms","volume":"17","author":"Huang","year":"2005","journal-title":"IEEE Trans knowledge Data Eng"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1466-8238.2007.00358.x","article-title":"AUC: a misleading measure of the performance of predictive distribution models","volume":"17","author":"Lobo","year":"2008","journal-title":"Global Ecol Biogeography"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.jtcvs.2017.12.107","article-title":"Nomogram: an analogue tool to deliver digital knowledge","volume":"155","author":"Park","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.37","article-title":"Decision curve analysis","volume":"313","author":"Fitzgerald","year":"2015","journal-title":"JAMA"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.687975","article-title":"IOBR: Multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures","volume":"12","author":"Zeng","year":"2021","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3186427","DOI":"10.1155\/2022\/3186427","article-title":"Immune infiltration analysis with the CIBERSORT method in lung cancer","volume":"2022","author":"Guan","year":"2022","journal-title":"Dis Markers"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/pst.426","article-title":"Guidelines for accurate EC50\/IC50 estimation","volume":"10","author":"Sebaugh","year":"2011","journal-title":"Pharm Stat"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"B42","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ccell.2024.02.002","article-title":"PDGFR\u03b1(+)ITGA11(+) fibroblasts foster early-stage cancer lymphovascular invasion and lymphatic metastasis via ITGA11-SELE interplay","volume":"42","author":"Zheng","year":"2024","journal-title":"Cancer Cell"},{"key":"B43","article-title":"Ellinger J: Serum DNA hypermethylation in patients with bladder cancer: Results of a prospective multicenter study","volume":"33","author":"Hauser","year":"2013","journal-title":"Anticancer Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskj\u00f8t","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"B45","doi-asserted-by":"publisher","first-page":"a036863","DOI":"10.1101\/cshperspect.a036863","article-title":"New approaches on cancer immunotherapy","volume":"10","author":"Cha","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1276602","article-title":"Actin cytoskeleton remodeling at the cancer cell side of the immunological synapse: Good, bad, or both","volume":"14","author":"Ockfen","year":"2023","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2016.1236877","article-title":"Role of actin in shaping autophagosomes","volume":"12","author":"Zientara-Rytter","year":"2016","journal-title":"Autophagy"},{"key":"B48","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","article-title":"Immunogenic cell stress and death","volume":"23","author":"Kroemer","year":"2022","journal-title":"Nat Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"102253","DOI":"10.1016\/j.coi.2022.102253","article-title":"Oncogenic viruses, cancer biology, and innate immunity","volume":"78","author":"White","year":"2022","journal-title":"Curr Opin Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12199-018-0740-1","article-title":"Inflammation and cancer","volume":"23","author":"Murata","year":"2018","journal-title":"Environ Health Prev Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12935-019-0950-7","article-title":"A six-gene prognostic model predicts overall survival in bladder cancer patients","volume":"19","author":"Wang","year":"2019","journal-title":"Cancer Cell Int"},{"key":"B52","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1186\/s12885-021-08687-7","article-title":"A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer","volume":"21","author":"Liang","year":"2021","journal-title":"BMC Cancer"},{"key":"B53","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1038\/s41467-021-25354-4","article-title":"Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-020-0174-0","article-title":"Cholesterol metabolism in cancer: Mechanisms and therapeutic opportunities","volume":"2","author":"Huang","year":"2020","journal-title":"Nat Metab"},{"key":"B55","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/15384101.2018.1558868","article-title":"CYP27A1 inhibits bladder cancer cells proliferation by regulating cholesterol homeostasis","volume":"18","author":"Liang","year":"2019","journal-title":"Cell Cycle"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2014.04.018","article-title":"Estrogen metabolism and breast cancer","volume":"356","author":"Samavat","year":"2015","journal-title":"Cancer Lett"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-030212-183708","article-title":"Estrogen and cancer","volume":"75","author":"Liang","year":"2013","journal-title":"Annu Rev Physiol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/med.21948","article-title":"Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds","volume":"43","author":"Ang","year":"2023","journal-title":"Med Res Rev"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.celrep.2019.04.048","article-title":"Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer","volume":"27","author":"Guo","year":"2019","journal-title":"Cell Rep"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-009-9194-7","article-title":"Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer","volume":"28","author":"McConkey","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12096","article-title":"Expression of HMGA2 in bladder cancer and its association with epithelial-to-mesenchymal transition","volume":"47","author":"Ding","year":"2014","journal-title":"Cell Prolif"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1530\/erc-14-0549","article-title":"Cell-cycle-dependent regulation of androgen receptor function","volume":"22","author":"Koryakina","year":"2015","journal-title":"Endocrine-related Cancer"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-023-00761-y","article-title":"The androgen receptor in bladder cancer","volume":"20","author":"Chen","year":"2023","journal-title":"Nat Rev Urol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/cancers9020020","article-title":"Androgen receptor signaling in bladder cancer","volume":"9","author":"Li","year":"2017","journal-title":"Cancers (Basel)"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1505","article-title":"The role of the unfolded protein response in tumour development: Friend or foe","volume":"4","author":"Ma","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2014.07.006","article-title":"The unfolded protein response as a target for cancer therapy","volume":"1846","author":"Nagelkerke","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"B67","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3390\/cells10040842","article-title":"Understand KRAS and the quest for anti-cancer drugs","volume":"10","author":"Han","year":"2021","journal-title":"Cells"},{"key":"B68","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ccell.2020.03.016","article-title":"Cathepsin S Regulates Antigen Processing and T Cell Activity in Non-Hodgkin Lymphoma","volume":"37","author":"Dheilly","year":"2020","journal-title":"Cancer Cell"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3109\/15476910903204058","article-title":"AnnexinA5 renders dead tumor cells immunogenic\u2013implications for multimodal cancer therapies","volume":"6","author":"Frey","year":"2009","journal-title":"J Immunotoxicol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41467-020-14821-z","article-title":"Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment","volume":"11","author":"Kang","year":"2020","journal-title":"Nat Commun"},{"key":"B71","doi-asserted-by":"publisher","first-page":"8129","DOI":"10.1038\/s41598-024-58550-5","article-title":"Pan-cancer analysis reveals IL32 is a potential prognostic and immunotherapeutic biomarker in cancer","volume":"14","author":"Han","year":"2024","journal-title":"Sci Rep"},{"key":"B72","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.3390\/cancers14153596","article-title":"FXYD3 expression predicts poor prognosis in renal cell carcinoma with immunosuppressive tumor microenvironment","volume":"14","author":"Yonekura","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B73","doi-asserted-by":"publisher","first-page":"127312","DOI":"10.1016\/j.ijbiomac.2023.127312","article-title":"Selection of goat \u03b2-casein derived ACE-inhibitory peptide SQPK and insights into its effect and regulatory mechanism on the function of endothelial cells","volume":"253","author":"Wu","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202002054","article-title":"Engineering macrophages for cancer immunotherapy and drug delivery","volume":"32","author":"Xia","year":"2020","journal-title":"Adv Mater"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-34025-4_9","article-title":"Monocytes and macrophages in cancer: Unsuspected roles","volume":"1219","author":"Gouveia-Fernandes","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.4RI0818-311R","article-title":"Monocyte heterogeneity and functions in cancer","volume":"106","author":"Olingy","year":"2019","journal-title":"J Leukoc Biol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","article-title":"Clinical and therapeutic relevance of cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2016.09.003","article-title":"T-cell immunometabolism against cancer","volume":"382","author":"Jiang","year":"2016","journal-title":"Cancer Lett"},{"key":"B80","doi-asserted-by":"publisher","first-page":"105880","DOI":"10.1016\/j.intimp.2019.105880","article-title":"A review on the role of M2 macrophages in bladder cancer; pathophysiology and targeting","volume":"76","author":"Sharifi","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3892\/or.2019.7196","article-title":"Tumor\u2212infiltrating M2 macrophages driven by specific genomic alterations are associated with prognosis in bladder cancer","volume":"42","author":"Xue","year":"2019","journal-title":"Oncol Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1572034\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T05:26:46Z","timestamp":1745299606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1572034\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":81,"alternative-id":["10.3389\/fimmu.2025.1572034"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1572034","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"article-number":"1572034"}}